Hirokazu Shoji, Narikazu Boku, Jun Adachi. Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies. Cancer Science. 2026
Tanaka Y, Sakahara M, Yamanaka H, Natsume Y, Kusama D, Kumegawa K, Yoshikawa H, Abe Y, Okabayashi K, Matui S, et al. Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer. Nature communications. 2025
Hirokazu Shoji, Daisuke Takahari, Akira Ooki, Hidekazu Hirano, Natsuko Okita, Kengo Nagashima, Jun Adachi, Kensei Yamaguchi, Ken Kato, Narikazu Boku. Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer. Scientific Reports. 2025
Kazuyuki Sogawa, Riko Yonekubo, Momori Shimizu, Satoshi Muraoka, Jun Adachi, Shigetsugu Takano, Hirotaka Takizawa, Masayuki Ohtsuka, Takeshi Tomonaga. Serum fucosylated receptor expression-enhancing protein 5 as a biomarker for early stage pancreatic cancer. Oncology letters. 2025. 30. 6. 556-556
Yuya Shirai, Takatoshi Enomoto, Yoshito Takeda, Ryuya Edahiro, Miho Takahashi-Itoh, Yoshimi Noda, Yuichi Adachi, Mana Nakayama, Takahiro Kawasaki, Taro Koba, et al. Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis. Journal of translational medicine. 2025. 23. 1. 1102-1102
Development of a highly sensitive, reproducible and rapid blood EV proteome analysis platform for large-scale cohort samples.
(ISEV2025 Annual Meeting 2025)
Longitudinal Phosphoproteomics Reveals PI3K-PAK1 Axis as a Potential Target for Recurrent Colorectal Liver Metastases.
(Keystone Symposia Precision Oncology 2025)